Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics
10.1016/j.clnu.2009.12.004 · 2010
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
10.1093/ajcn/83.6.1345 · 2006
Definition and classification of cancer cachexia: an international consensus
10.1016/s1470-2045(10)70218-7 · 2011
Cancer-associated cachexia
10.1038/nrdp.2017.105 · 2018
Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients
10.1007/s00520-012-1697-z · 2013
Cancer cachexia, mechanism and treatment
10.4251/wjgo.v7.i4.17 · 2015
Mechanisms of cancer cachexia and targeted therapeutic strategies
10.1016/j.bbcan.2024.189208 · 2024
Cancer cachexia: Focus on cachexia factors and inter-organ communication
10.1097/cm9.0000000000002846 · 2024
Elucidating the mechanism of traditional Chinese medicine formula (Yifei-sanjie Pill) in alleviating the chemobrain based on network pharmacology and experimental verification
10.1016/j.jtcme.2024.11.008 · 2026
Yifei sanjie pills alleviate chemotherapy-related fatigue by reducing skeletal muscle injury and inhibiting tumor growth in lung cancer mice
10.1155/2022/2357616 · 2022
Muscle wasting diseases: novel targets and treatments
10.1146/annurev-pharmtox-010818-021041 · 2019
The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states
10.1016/0165-6147(96)10021-3 · 1996
The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation
10.1152/ajpcell.00125.2016 · 2016
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
10.1152/ajpendo.00204.2014 · 2014
MG53 nucleates assembly of cell membrane repair machinery
10.1038/ncb1812 · 2009
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1
10.1038/s41392-023-01458-9 · 2023
MG53-IRS-1 (Mitsugumin 53-insulin receptor substrate-1) interaction disruptor sensitizes insulin signaling in skeletal muscle
10.1074/jbc.m116.754424 · 2016
TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1
10.1038/cdd.2010.1 · 2010
MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling
10.1038/ncomms3354 · 2013
An MG53-IRS1-interaction disruptor ameliorates insulin resistance
10.1038/s12276-018-0099-9 · 2018
Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders
10.1038/nature11834 · 2013
Serum MG53/TRIM72 is associated with the presence and severity of coronary artery disease and acute myocardial infarction
10.3389/fphys.2020.617845 · 2020
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography
10.1152/jappl.1998.85.1.115 · 1998
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors
10.1007/s10120-020-01124-x · 2021
Survival and CT defined sarcopenia in patients with intestinal failure on home parenteral support
10.1016/j.clnu.2019.03.015 · 2020
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
10.1016/s1470-2045(08)70153-0 · 2008
Sarcopenia and low muscle radiodensity associate with impaired FEV(1) in allogeneic haematopoietic stem cell transplant recipients
10.1002/jcsm.12604 · 2020
CT body composition of sarcopenia and sarcopenic obesity: predictors of postoperative complications and survival in patients with locally advanced esophageal adenocarcinoma
10.3390/cancers13122921 · 2021
CT-quantified muscle and fat change in patients after surgery or endoscopic resection for early gastric cancer and its impact on long-term outcomes
10.1097/md.0000000000013878 · 2018
The impact and clinical prediction of hyperglycemia during parenteral nutrition for nondiabetic patients after gastrectomy for gastric cancer
10.3389/fnut.2022.807841 · 2022
Establishment of a benign meningioma cell line by hTERT-mediated immortalization
10.1038/labinvest.3700307 · 2005
Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway
10.1016/j.phymed.2021.153858 · 2022
Exploring the therapeutic potential of ethyl 3-hydroxybutyrate in alleviating skeletal muscle wasting in cancer cachexia
10.3390/biom13091330 · 2023
Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity
10.1038/cdd.2011.206 · 2012
The inverse F-BAR domain protein srGAP2 acts through srGAP3 to modulate neuronal differentiation and neurite outgrowth of mouse neuroblastoma cells
10.1371/journal.pone.0057865 · 2013
Anti-cytokines in the treatment of cancer cachexia
10.21037/apm.2018.07.06 · 2019
A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange
10.1073/pnas.93.22.12631 · 1996
CT-determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia
10.1002/cam4.5040 · 2023
Molecular subtypes of human skeletal muscle in cancer cachexia
10.1038/s41586-025-09502-0 · 2025
MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma
10.7150/ijbs.67869 · 2022
